Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Clearpoint Neuro Inc (NQ: CLPT )

11.80 -0.04 (-0.34%)
Streaming Delayed Price Updated: 10:44 AM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Clearpoint Neuro Inc

< Previous 1 2 3 Next >
ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery
From ClearPoint Neuro, Inc.
Via GlobeNewswire
ClearPoint Neuro: Q1 Earnings Insights
Via Benzinga
3 Healthcare Stocks With Huge Growth Potential
It's been a tough time for the tech industry. So consider these healthcare growth stocks to buy now instead. 
Via InvestorPlace
Earnings Scheduled For March 1, 2023
Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million. 
Via Benzinga
ClearPoint Neuro's Earnings: A Preview
ClearPoint Neuro (NASDAQ:CLPT) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that ClearPoint... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time for another look at the biggest pre-market stock movers as we check out what's happening with shares on Tuesday morning! 
Via InvestorPlace
ClearPoint Neuro Secures FDA Nod For ClearPoint Prism Neuro Laser Therapy System
Via Benzinga
FDA Approves ClearPoint Neuro's Updated Software For Guidance System For Neurological Procedures
Via Benzinga
ClearPoint Neuro: Q2 Earnings Insights
  ClearPoint Neuro (NASDAQ:CLPT) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings ClearPoint Neuro reported... 
Via Benzinga
Recap of Tuesday's Biotech Catalysts - End Of the Day Summary
Via Benzinga
ClearPoint Shares Climb as FDA Announced Clearance To Maestro Brain Model Software
ClearPoint Neuro (NASDAQ: CLPT) announced the U.S. Food and Drug Administration (FDA) 510(k) clearance to its Maestro Brain Model, intended for automatic labeling, visualization, volumetric and shape... 
Via Benzinga
ClearPoint Neuro's Return On Capital Employed Insights
According to data from Benzinga Pro, during Q1, ClearPoint Neuro's (NASDAQ:CLPT) reported sales totaled $5.03 million. Despite a 4.58% increase in earnings, the company posted a loss of $3.96 million. 
Via Benzinga
Again, Buy ‘Em
Today we discuss again why it’s time to start adding back risk. We cover the major breadth thrusts that fired, some great monthly charts, and more. 
Via Talk Markets
38 Stocks Moving In Friday's Mid-Day Session
Gainers Leju Holdings Limited (NYSE: LEJU) surged 27.8% to $4.0413. 
Via Benzinga
66 Biggest Movers From Friday
Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) shares surged 90.2% to settle at $1.39 on Friday. GeoVax Labs, last month, said its Q1 sales results were lower year over year. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers 
Via Benzinga
Earnings Scheduled For March 1, 2022
Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated... 
Via Benzinga
90 Biggest Movers From Yesterday
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) surged 70.5% to close at $0.1330 on Thursday after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered... 
Via Benzinga
58 Stocks Moving In Thursday's Mid-Day Session
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 102.6% to $0.1580 after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering. 
Via Benzinga
Recap: ClearPoint Neuro Q1 Earnings
ClearPoint Neuro (NASDAQ:CLPT) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings ClearPoint Neuro beat... 
Via Benzinga
ClearPoint Neuro: Q4 Earnings Insights
ClearPoint Neuro (NASDAQ:CLPT) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
56 Biggest Movers From Yesterday
Gainers HOOKIPA Pharma Inc. (NASDAQ: HOOK) gained 54.5% to close at $2.07 on Wednesday. Hookipa Pharma amended and restated collaboration and license agreement with Gilead... 
Via Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
Gainers HOOKIPA Pharma Inc. (NASDAQ: HOOK) jumped 52.8% to $2.0478. Hookipa Pharma amended and restated collaboration and license agreement with Gilead Sciences for arenaviral... 
Via Benzinga
The Daily Biotech Pulse: Avenue Tumbles On Negative Adcom Verdict, Moderna's Expanded Deal With Rovi, Gilead Takes Equity Stake In Hookipa
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Hookipa Gets $15M Upfront Payment And Equity Investment From Gilead Following... 
Via Benzinga
23 Stocks Moving in Wednesday's Pre-Market Session
Gainers HOOKIPA Pharma Inc. (NASDAQ: HOOK) rose 41.8% to $1.90 in pre-market trading after the company announced it entered into an amended and restated collaboration... 
Via Benzinga
ClearPoint Neuro, Inc. (CLPT) Q3 2021 Earnings Call Transcript
CLPT earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Longeveron (NASDAQ:LGVN) shares ... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Stealth BioTherapeutics (NASDAQ: 
Via Benzinga
ClearPoint Neuro Stock Dives After Q2 Earnings
ClearPoint Neuro Inc (NASDAQ: CLPT) reported Q2 revenue of $3.4 million, a 38% Y/Y increase, below the consensus estimate of $3.68 million. Functional neurosurgery... 
Via Benzinga
66 Biggest Movers From Yesterday
Gainers Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) shares jumped 50.5% to close at $20.74 on Wednesday. The company, last month, priced its IPO at $11 per share. Dyadic... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.